Pierre Delobel

15PUBLICATIONS
44CO-AUTHORS
Innate immunityNaturopathyMedical virologyGenome structure and regulationDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 14, 2026
Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins.

|Nov 04, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.

Romain Palich, Jade Ghosn, Karine Lacombe

|Sep 10, 2025
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies.

Clément Viguier, Pierre Delobel, François-Xavier Lescure

|Sep 08, 2025
Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy.

Nived Collercandy, Camille Vellas, Manon Nayrac

|Nov 19, 2024
Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral Therapy.

Camille Vellas, Dorine Martres, Mary Requena

|Jan 17, 2023
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.

Matthew G Johnson, Julie M Strizki, Michelle L Brown

Pageof 3

Frequent Collaborators

3 joint publications

Camille Vellas

3 joint publications

Bernard Lagane

2 joint publications

Stéphanie Raymond

2 joint publications

Clotilde Allavena